Szyman Catherine M.'s Form 4 filing
Edwards Lifesciences Corp (EW) · filed Jul 10, 2023
- Accession no.
- 0001225208-23-007434
- Filed
- Jul 10, 2023
- Trade date
- Jul 7-10, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $452.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Szyman Catherine M.CIK 0001438538 | Officer (CVP, Critical Care) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2023 | Common Stock | FTax withholdingDisposed | −252 | $90.46 | −$22,795.92 | 34,813.57 | Direct | |
| Jul 10, 2023 | Common Stock | MOption exerciseAcquired | +5,000 | $36.75 | +$183,750 | 39,813.57 | Direct | |
| Jul 10, 2023 | Common Stock | SSaleDisposed | −5,000 | $90.52 | −$452,600 | 34,813.57 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2023 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 62,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.